SNY

Q: What is the price of Sanofi (SNY) today?

The current price of Sanofi (SNY) is $ 47.37, representing a -3.41% gain over the past year. The stock began the year trading around $ 48.46 and is currently priced at $ 47.37. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Sanofi (SNY) pay dividends?

Sanofi (SNY) did not pay dividends over the past year.

Q: Is Sanofi (SNY) a good investment?

Sanofi (SNY) is currently trading at $ 47.37 with a P/E ratio of 12.82%. This represents a 1,030% premium compared to its historical average P/E. Over the past year, the stock has gained -3.41 and paid $ 0.00 in dividends, resulting in a dividend yield of 4.62%. The total shareholder return over the same period was -3.41%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Sanofi

Price

$ 47.37

return (12m)

-3.41%

p/e

12.82

p/bv

1.39

DIVIDEND YIELD

4.62%

SNY price

SNY

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment SNY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

7.72%

3 months

-3.40%

1 year

-3.41%

2 years

8.61%

5 years

14.92%

10 years

67.93%

Fundamentals SNY

review the fundamentals of Sanofi shares

P/E

12.82

Sector: -2.15 Industry: 0.38

P/S (PSR)

2.39

Sector: 1.92 Industry: 2.43

P/BV

1.39

Sector: 2.10 Industry: 2.24

DIVIDEND YIELD (DY)

4.62%

Sector: - Industry: -

ROA

6.14%

Sector: -25.33% Industry: -23.48%

ROE

10.86%

Sector: -29.65% Industry: -31.19%

ROIC

0.00%

Sector: -418.66% Industry: -76.94%

NET MARGIN

18.68%

Sector: -27.82% Industry: -30.15%

GROSS MARGIN

71.01%

Sector: 44.91% Industry: 51.03%

OPERATING MARGIN

19.80%

Sector: -22.85% Industry: -26.89%

EV/EBITDA

10.21

Sector: -0.40 Industry: 1.11

EV/EBIT

14.90

Sector: -1.68 Industry: -0.22

PRICE-TO-ASSETS

0.79

Sector: 1.13 Industry: 1.20

BVPS

34.40

Sector: 3.83 Industry: 5.09

EPS

3.74

Sector: -0.89 Industry: -0.80

EQUITY-TO-ASSETS RATIO

0.57

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

0.43

Sector: 0.46 Industry: 0.50

CAGR REVENUE 5 YEARS

1.38%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

4.73%

Sector: - Industry: -

FAIR VALUE OF Sanofi ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 47.37

Fair Value

$ 0.00

Upside/Downside Return potential.

13.59%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals SNY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%
CI	10.45	0.00	0.00%	2.26%	$ 71.83 B	2.50%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

SNY Historical Dividends

current DY: 4.62%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	05/09/2025	06/12/2025	2,21210000
Dividends	05/10/2024	06/06/2024	2,03740000
Dividends	05/31/2023	06/23/2023	1,90310000
Dividends	05/05/2022	06/08/2022	1,79680000
Dividends	05/04/2021	05/26/2021	1,90610000
Dividends	05/01/2020	05/26/2020	1,75300000
Dividends	05/08/2019	05/31/2019	1,73900000
Dividends	05/10/2018	06/04/2018	1,86100000
Dividends	05/15/2017	06/07/2017	1,57700000
Dividends	05/09/2016	06/01/2016	1,63000000
Dividends	05/08/2015	06/02/2015	1,60930000
Dividends	05/09/2014	06/05/2014	1,90980000
Dividends	05/08/2013	06/05/2013	1,86200000
Dividends	05/09/2012	05/30/2012	1,75600000
Dividends	05/13/2011	06/24/2011	1,82200000
Dividends	05/19/2010	06/14/2010	1,62700000
Dividends	04/22/2009	05/29/2009	1,41900000
Dividends	05/20/2008	06/13/2008	1,51000000
Dividends	06/06/2007	07/03/2007	1,14500000
Dividends	06/06/2006	07/03/2006	0,91200000
Dividends	06/06/2005	07/01/2005	0,79900000
Dividends	09/29/2004	10/05/2004	0,03080000
Dividends	05/04/2004	06/01/2004	0,58000000
Dividends	05/30/2003	06/26/2003	0,46200000

ABOUT Sanofi

Sanofi

Average Investor10 user rating

4.0 (114 people)

United States

32 years

Founded: 1994

2002

Time since IPO - 24 years

99.412

Employees

Sanofi operates in the Healthcare sector, within the Biopharmaceutical industry. The company develops and commercializes prescription medicines and vaccines globally.

Its portfolio includes:

Specialty care and immunology therapies.
Oncology treatments.
Rare disease medicines.
Diabetes and cardiovascular products.
Vaccines through its global immunization division.

Sanofi maintains a broad international footprint, with the United States representing a major commercial market. Operations include clinical research, biotechnology development, large-scale manufacturing, and regulated global distribution.

Performance is influenced by patent cycles, regulatory approvals, pricing policy, competition from multinational pharmaceutical companies, vaccine demand, and research and development productivity.

Sanofi shares trade on the Nasdaq under the ticker SNY.

History and Development

Sanofi was founded in 1973 in France as part of a broader reorganization within the French pharmaceutical and chemical industries.

Over the following decades, the company expanded internationally and strengthened its therapeutic portfolio through acquisitions, including the integration of Aventis, which significantly expanded its global scale and vaccine operations.

In recent years, Sanofi has increased its focus on immunology and specialty medicines, invested in biotechnology platforms, streamlined portions of its legacy portfolio, and reinforced its vaccine and rare disease franchises to support long-term growth.

Additional Information

Sanofi (United States) is listed on the Nasdaq and has a market capitalization of $116.90 Billions, with shareholders equity totaling $83.97 Billions.

The company employs approximately 99.412 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Sanofi reported $48.83 Billions in revenue, generating net income of $9.12 Billions.

Key financial metrics include a P/E ratio of 12.82, a price-to-book (P/B) ratio of 1.39, and a trailing twelve-month dividend yield of 4.62%.

The company trades under the ticker SNY.

Market cap

$ 116.90 Billions

Net worth

$ 83.97 Billions

$ 83,969,550,000.00

Assets

$ 148.48 Billions

$ 148,483,610,000.00

Total Shares Outstanding

2.44 Billions

2,441,000,000

Average Daily Trading Volume

$ 4.29 Millions

$ 4,289,084.46

Sector

Health

Industry

Pharmaceutical Products

SNY

revenue by Business Segment Sanofi

Revenue by Region Sanofi

SNY revenue and profits

Financial Results SNY

DRAG THE FRAME TO SEE MORE DATA

SNY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.16 20,24% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 278.37 --13,14% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 37.27 --40,26% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 197.45 --30,67% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 959.08 31,90% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 155.47 58,82% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 79.16 20,24% (12 M)

P/L

52.79

3.62%

ROE

2.35%

P/VP

1.24

CI - Cigna

$ 278.37 --13,14% (12 M)

P/L

10.45

2.26%

ROE

0.00%

P/VP

0.00

CNC - Centene

$ 37.27 --40,26% (12 M)

P/L

-2.59

0.00%

ROE

-33.28%

P/VP

0.86

HUM - Humana

$ 197.45 --30,67% (12 M)

P/L

17.96

1.99%

ROE

6.70%

P/VP

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12 M)

P/L

15.86

0.62%

ROE

-244.82%

P/VP

-38.82

LLY - Eli Lilly

$ 959.08 31,90% (12 M)

P/L

40.57

0.67%

ROE

86.53%

P/VP

35.11

NVS - Novartis

$ 155.47 58,82% (12 M)

P/L

21.09

4.53%

ROE

30.04%

P/VP

6.34

Frequently Asked Questions

What is the price of Sanofi (SNY) today?

The current price of Sanofi (SNY) is $ 47.37, representing a -3.41% gain over the past year. The stock began the year trading around $ 48.46 and is currently priced at $ 47.37. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Sanofi (SNY) pay dividends?

Sanofi (SNY) did not pay dividends over the past year.

Is Sanofi (SNY) a good investment?

Sanofi (SNY) is currently trading at $ 47.37 with a P/E ratio of 12.82%. This represents a 1,030% premium compared to its historical average P/E. Over the past year, the stock has gained -3.41 and paid $ 0.00 in dividends, resulting in a dividend yield of 4.62%. The total shareholder return over the same period was -3.41%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Sanofi (SNY) stock?

You can buy Sanofi (SNY) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol SNY and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Sanofi (SNY) yield today?

Over the past month, Sanofi (SNY) has returned 7.72% — -3.41% over the past year, and 14.92% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 2.21 per share in dividends, resulting in a dividend yield of 4.62%.

If you were to purchase 100 shares of Sanofi (SNY) today at the current price of $ 47.37 your total investment would be $ 4,736.50.

Based on historical performance, the investment would have grown to approximately:

$ 4,574.99 after 1 year
$ 5,443.19 after 5 years
$ 7,954.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SNY

Sanofi

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SNY

review the fundamentals of Sanofi shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 4.62%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Sanofi

Sanofi

United States

32 years

2002

99.412

History and Development

Additional Information

PROFIT X PRICE SNY

Financial Results SNY

SNY cash flow

Asset, Revenue and Profit Growth - SNY

SNY balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

Frequently Asked Questions